bromodeoxyuridine has been researched along with dexefaroxan in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Colpaert, F; Debeir, T; Marien, M; Raisman-Vozari, R; Rizk, P; Ruberg, M; Salazar, J | 1 |
1 other study(ies) available for bromodeoxyuridine and dexefaroxan
Article | Year |
---|---|
The alpha2-adrenoceptor antagonist dexefaroxan enhances hippocampal neurogenesis by increasing the survival and differentiation of new granule cells.
Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Benzopyrans; Brain-Derived Neurotrophic Factor; Bromodeoxyuridine; Cell Count; Cell Differentiation; Cell Survival; Chromatography, High Pressure Liquid; Hippocampus; Imidazoles; Immunohistochemistry; In Situ Nick-End Labeling; Male; Microdialysis; Neural Cell Adhesion Molecule L1; Neurons; Norepinephrine; Rats; Rats, Sprague-Dawley; Sialic Acids; Time Factors | 2006 |